EX-99.1 2 v431949_ex99-1.htm EXHIBIT 99.1

Exhibit 99.1

 

Sapiens Logo notag.jpg

 

 

Sapiens Reports 16.5% Revenue Growth in Q4 2015

 

Full-Year Revenue Growth of 13.9% and Diluted Earnings Per Share Growth of 36.2%

  

Holon, Israel, February 17, 2016Sapiens International Corporation, (NASDAQ and TASE: SPNS), a leading global provider of software solutions for the insurance industry, with an emerging focus on the broader financial services sector, and a member of the Formula Group (NASDAQ: FORTY and TASE: FORT), today announced its financial results for the fourth quarter and year ended December 31, 2015.

 

Fourth Quarter Highlights:

 

·Non-GAAP revenue of $48.7 million, up 16.5% compared to $41.8 million in the fourth quarter of 2014.

 

·Non-GAAP operating profit increased by 48.4% and totaled $7.4 million (15.1% operating margin), compared to $5.0 million (11.9% operating margin) in the fourth quarter of 2014.

 

·Non-GAAP net income attributable to Sapiens’ shareholders totaled $6.3 million or $0.13 per diluted share, an increase of 28.0% compared to $4.9 million or $0.10 per diluted share in the fourth quarter last year.

 

·Cash, cash equivalents and securities investments as of December 31, 2015 was $94.0 million and the company has no debt.

 

Full Year Financial Highlights:

 

·Non-GAAP revenue increased by 13.9% to $179.3 million from $157.5 million in the same period of 2014. Excluding the impact of foreign currency exchange rates, revenue growth exceeded 20%.

 

·Non-GAAP operating profit was $26.5 million (14.8% operating margin), compared to $17.0 million (10.8% operating margin) in 2014, an increase of 56.0%.

 

·Non-GAAP net income attributable to Sapiens’ shareholders reached $22.1 million, or $0.45 per diluted share compared to $16.0 million, or $0.33 per diluted share in the year ago period, an increase of 36.2%.

 

1  
 

 

“We again delivered double-digit growth and improved performance across all of our offerings, from all geographies, and from both new and existing customers due to continued strong demand for our award-winning products and services,” said Roni Al-Dor, President and CEO of Sapiens. “Our efforts to more efficiently leverage our operations and improve our operating margins enabled us to grow our bottom line, and we are well positioned to continue our revenue and profitability growth into 2016 and beyond.”

 

Mr. Al-Dor continued. “Our strategic acquisitions of IBEXI in India and Insseco in Poland are clearly paying off, allowing us to increase our presence and support customers through new regional delivery and development centers in those markets. We expect to continue our acquisition strategy in 2016 to expand our geographic footprint and to enhance our product offerings. With new recent business wins across all our product lines, including our recently announced $30 million business expansion with a leading North American insurance company, we are confident for continued double-digit growth in 2016.”

 

Mr. Al-Dor concluded: “Longer term, our expanded global presence and increasingly comprehensive suite of solutions will drive continued growth, and we remain enthusiastic about the near-term and long-term prospects for our markets and our strategic position as an innovative provider of advanced, industry-leading software solutions.”

 

2016 Business Outlook

Management indicated it expects 2016 full year revenues of $207 to $211 million, a growth of 15.4%-17.7%.

The company also expects full-year 2016 Non-GAAP operating margins in the range of 15.0% - 15.5%.

 

Quarterly Results Conference Call

Management will host a conference call and webcast today, February 17, at 9:30 a.m. Eastern Time (4:30 p.m. in Israel) to review and discuss Sapiens’ results. Please call the following numbers (at least 10 minutes before the scheduled time) to participate:

North America (toll-free): + 1-866-860-9642; International: +972-3-918-0664; UK: 0-800-917-9141

The live webcast of the call can be viewed on Sapiens’ website at: http://www.sapiens.com/investors/presentations-and-webcast/

 

2  
 

 

If you are unable to join live, a replay of the call will be accessible until February 27, 2016, as follows:

North America: 1-888-782-4291; International: +972-3-925-5901

A recorded version of the webcast will also be available via the Sapiens website, for three months at the same location.

 

 

Non-GAAP Financial Measures

 

This press release contains the following non-GAAP financial measures: Non-GAAP revenue, Non-GAAP gross profit, Non-GAAP operating income, Non-GAAP net income attributed to Sapiens shareholders, Non-GAAP basic and diluted earnings per share.

 

Sapiens believes that these non-GAAP measures of financial results provide useful information to management and investors regarding certain financial and business trends relating to Sapiens' financial condition and results of operations. The Company's management uses these non-GAAP measures to compare the Company's performance to that of prior periods for trend analyses, for purposes of determining executive and senior management incentive compensation and for budgeting and planning purposes. These measures are used in financial reports prepared for management and in quarterly financial reports presented to the Company's board of directors. The Company believes that the use of these non-GAAP financial measures provides an additional tool for investors to use in evaluating ongoing operating results and trends and in comparing the Company's financial measures with other software companies, many of which present similar non-GAAP financial measures to investors.

 

Management of the Company does not consider these non-GAAP measures in isolation or as an alternative to financial measures determined in accordance with GAAP. The principal limitation of these non-GAAP financial measures is that they exclude significant expenses and income that are required by GAAP to be recorded in the Company's financial statements. In addition, they are subject to inherent limitations as they reflect the exercise of judgment by management about which expenses and income are excluded or included in determining these non-GAAP financial measures. In order to compensate for these limitations, management presents non-GAAP financial measures in connection with GAAP results. Sapiens urges investors to review the reconciliation of its non-GAAP financial measures to the comparable GAAP financial measures, which it includes in press releases announcing quarterly financial results, including this press release, and not to rely on any single financial measure to evaluate the Company's business.

 

3  
 

 

In addition, the Company adjusted revenues and expenses, recorded under US GAAP, of pre-acquisition date in respect of acquired business from its ultimate parent company. As this transaction is between companies under common control, under US GAAP, it was accounted for under the pooling of interest method. For non-GAAP measurement purposes, the Company excludes the pre-acquisition date revenues and expenses.

 

Reconciliation tables of the most comparable GAAP financial measures to the non-GAAP financial measures used in this press release are included with the financial tables of this release.

 

The Company defines Adjusted EBITDA as net Profit, adjusted for stock-based compensation expense, depreciation and amortization, capitalized internal-use software development costs, amortization of internal-use software development costs interest expense, compensation expenses related to acquisition, pre-acquisition revenues and expenses accounted under pooling of interest method, provision for income taxes and other income (expenses). These amounts are often excluded by other companies to help investors understand the operational performance of their business. The Company uses Adjusted EBITDA as a measurement of its operating performance because it assists in comparing the operating performance on a consistent basis by removing the impact of certain non-cash and non-operating items. Adjusted EBITDA reflect an additional way of viewing aspects of the operations that the Company believes, when viewed with the GAAP results and the accompanying reconciliations to corresponding GAAP financial measures provide a more complete understanding of factors and trends affecting its business.

 

About Sapiens

 

Sapiens International Corporation (NASDAQ and TASE: SPNS) is a leading global provider of software solutions for the insurance industry, with an emerging focus on the broader financial services sector. We offer core, end-to-end solutions to the global general insurance, property and casualty, life, pension and annuities, and retirement markets, as well as business decision management software. We have a track record of over 30 years in delivering superior software solutions to more than 190 financial services organizations. The Sapiens team of approximately 1,600 professionals operates through our fully-owned subsidiaries in North America, the United Kingdom, EMEA and Asia Pacific. For more information: www.sapiens.com.

 

4  
 

 

Forward Looking Statement

 

Some of the statements in this press release may constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities and Exchange Act of 1934 and the United States Private Securities Litigation Reform Act of 1995. Words such as "will," "expects," "believes" and similar expressions are used to identify these forward-looking statements (although not all forward-looking statements include such words). These forward-looking statements, which may include, without limitation, projections regarding our future performance and financial condition, are made on the basis of management's current views and assumptions with respect to future events. Any forward-looking statement is not a guarantee of future performance and actual results could differ materially from those contained in the forward-looking statement.

 

These statements speak only as of the date they were made, and we undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. We operate in a changing environment. New risks emerge from time to time and it is not possible for us to predict all risks that may affect us. For more information regarding these risks and uncertainties, as well as certain additional risks that we face, please refer to the Risk Factors detailed in Item 3 of Part III of our Annual Report on Form 20-F for the year ended December 31, 2014, and subsequent reports and registration statements filed from time to time with the Securities and Exchange Commission.

 

 

Investors and Media Contact:

 

Yaffa Cohen-Ifrah

 

Chief Marketing Officer and Head of Corporate Communications

Sapiens International

US Mobile: +1 201-250-9414

Mobile: +972 54-9099039

Email: yaffa.cohen-ifrah@sapiens.com

 

5  
 

 

Summary of Non-GAAP financial Information

U.S. dollars in thousands (except per share amounts)

 

   Three months ended   Year ended 
   December 31,   December 31, 
   2015   2014   2015   2014 
   (unaudited)   (unaudited)   (unaudited)   (unaudited) 
                                 
Revenues   48,674    100%   41,773    100%   179,263    100%   157,450    100%
                                         
Gross Profit   21,515    44.2%   17,478    41.8%   78,472    43.8%   64,193    40.8%
                                         
Operating profit   7,356    15.1%   4,958    11.9%   26,547    14.8%   17,014    10.8%
                                         
Net income to shareholders   6,332    13.0%   4,948    11.8%   22,105    12.3%   16,008    10.2%
                                         
Adjusted EBITDA   7,928    16.3%   5,363    12.8%   28,499    15.9%   18,596    11.8%
                                         
Basic earnings per share   0.13         0.10         0.46         0.34      
Diluted earnings per share   0.13         0.10         0.45         0.33      

 

 

 

Adjusted EBITDA Calculation
U.S. dollars in thousands

 

   Three months ended   Year ended 
   December 31,   December 31, 
   2015   2014   2015   2014 
                 
GAAP operating profit   6,796    4,550    24,350    14,906 
                     
Non GAAP adjustments:                    
Amortization of capitalized software   1,323    1,194    4,875    4,926 
Amortization of other intangible assets   392    544    2,106    2,209 
Capitalization of software development   (1,641)   (1,556)   (6,032)   (6,094)
Compensation related to acquisition   51    -    270    - 
Stock-based compensation   435    226    1,349    1,067 
Adjustments of pre-acquisition revenues and expenses accounted under pooling of interest method   -    -    (371)   - 
                     
Non GAAP operating profit   7,356    4,958    26,547    17,014 
                     
Depreciation   572    405    1,952    1,582 
                     
Adjusted EBITDA   7,928    5,363    28,499    18,596 

 

6  
 

 

Non-GAAP revenues by category
U.S. dollars in thousands

 

   Three months ended
December 31, 2015
   Year ended
 December 31, 2015
 
   Revenues   Percentage   Revenues   Percentage 
     
License   2,820    5.8%   12,300    6.9%
Services and Maintenance   45,854    94.2%   166,963    93.1%
Total   48,674    100.0%   179,263    100.0%

 

 

 

Non-GAAP revenues by geographic breakdown
U.S. dollars in thousands

 

  

Three months ended
December 31, 2015

  

Year ended
December 31, 2015

 
   Revenues   Percentage   Revenues   Percentage 
     
North America   16,767    34.4%   61,332    34.2%
Europe   26,439    54.3%   97,419    54.3%
APAC   5,468    11.3%   20,512    11.5%
Total   48,674    100%   179,263    100%

 

7  
 

 

SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

U.S. dollars in thousands (except per share amounts)

 

   Three months ended   Year ended 
   December 31,   December 31, 
   2015   2014   2015*   2014 
   (unaudited)   (unaudited)   (unaudited)   (unaudited) 
                 
Revenue   48,674    41,773    185,636    157,450 
Cost of revenue   28,633    25,731    111,192    99,095 
                     
Gross profit   20,041    16,042    74,444    58,355 
                     
Operating Expenses:                    
 Research and development, net   2,747    2,752           10, 235     11,352 
 Selling, marketing, general and administrative   10,498    8,740    39,859    32,097 
Total operating expenses   13,245    11,492    50,094    43,449 
                    
Operating income   6,796    4,550    24,350    14,906 
                     
Financial expenses (income), net   (402)   26    (163)   (124)
Taxes and other expenses (income), net   1,192    (88)   4,213    454 
                     
                     
Net income   6,006    4,612    20,300    14,576 
                     
Attributable to non-controlling interest   134    (12)   284    113 
                     
Net income attributable to Sapiens' shareholders   5,872    4,624    20,016    14,463 
                     
                     
Basic earnings per share   0.12    0.10    0.42    0.31 
                     
Diluted earnings per share   0.12    0.09    0.41    0.30 
                     
Weighted average number of shares outstanding used to compute basic earnings per share (in thousands)   48,758    47,655    48,121    47,210 
Weighted average number of shares outstanding used to compute diluted earnings per share (in thousands)   49,536    49,057    49,327    48,637 

 

 

* Including consolidation of Insseco commencing December 31, 2014.

 

8  
 

 

SAPIENS INTERNATIONAL CORPORATION N.V. AND SUBSIDIARIES

RECONCILIATION OF GAAP TO NON-GAAP RESULTS

U.S. dollars in thousands (except per share amounts)

 

   Three months ended   Year ended 
   December 31,   December 31, 
   2015   2014   2015*   2014 
GAAP revenue   48,674    41,773    185,636    157,450 
Adjustments of pre-acquisition revenue accounted under pooling of interest method   -    -    (6,373)   - 
Non-GAAP revenue   48,674    41,773    179,263    157,450 
                     
GAAP gross profit   20,041    16,042    74,444    58,355 
Revenue adjustment   -    -    (6,373)   - 
Amortization of capitalized software   1,323    1,194    4,875    4,926 
Amortization of other intangible assets   151    242    794    912 
Adjustments of pre-acquisition cost of revenue accounted under pooling of interest method   -    -    4,732    - 
Non-GAAP gross profit   21,515    17,478    78,472    64,193 
                     
                     
GAAP operating income   6,796    4,550    24,350    14,906 
Gross profit adjustments   1,474    1,436    4,028    5,838 
Capitalization of software development   (1,641)   (1,556)   (6,032)   (6,094)
Amortization of other intangible assets   241    302    1,312    1,297 
Stock-based compensation   435    226    1,349    1,067 
Compensation related to acquisition   51    -    270    - 
Adjustments of pre-acquisition operating expenses accounted under pooling of interest method   -    -    1,270    - 
Non-GAAP operating income   7,356    4,958    26,547    17,014 
                     
GAAP net income attributable to Sapiens' shareholders   5,872    4,624    20,016    14,463 
Operating income adjustments   560    408    2,197    2,108 
Adjustment to redeemable non-controlling interest   151    -    224    - 
Adjustments of pre-acquisition financial and tax expenses accounted under pooling of interest method   -    -    50    - 
Other   (251)   (84)   (382)   (563)
Non-GAAP net income attributable to Sapiens' shareholders   6,332    4,948    22,105    16,008 
                     
Non-GAAP basic earnings per share   0.13    0.10    0.46    0.34 
                     
Non-GAAP diluted earnings per share   0.13    0.10    0.45    0.33 
                     
Weighted average number of shares outstanding used to compute basic earnings per share (in thousands)   48,758    47,655    48,121    47,210 
Weighted average number of shares outstanding used to compute diluted earnings per share (in thousands)   49,536    49,057    49,327    48,637 

 

* Including consolidation of Insseco commencing the acquisition date, August 18, 2015.

 

9  
 

 

SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

U.S. Dollars in thousands

 

   December 31,   December 31, 
   2015   2014* 
   (unaudited)   (unaudited) 
         
 ASSETS          
           
 CURRENT ASSETS:          
Cash and cash equivalents   54,351    47,400 
Trade receivables, net   29,761    31,832 
Other receivables and prepaid expenses   5,455    3,964 
Marketable Securities   8,776    - 
           
Total current assets   98,343    83,196 
           
 LONG-TERM ASSETS:          
Marketable Securities   30,875    33,098 
Property and equipment, net   5,675    5,011 
Severance pay fund   5,551    10,735 
Other intangible assets, net   27,540    27,905 
Other long-term assets   4,252    5,567 
Goodwill   70,035    67,698 
           
Total long-term assets   143,928    150,014 
           
 TOTAL ASSETS   242,271    233,210 
           
LIABILITIES AND EQUITY          
           
 CURRENT LIABILITIES:          
Trade payables   4,721    3,310 
Accrued expenses and other liabilities   32,012    26,951 
Deferred revenue   10,268    9,272 
           
Total current liabilities   47,001    39,533 
           
 LONG-TERM LIABILITIES:          
Other long-term liabilities   6,414    3,217 
Accrued severance pay   6,662    12,008 
           
Total long-term liabilities   13,076    15,225 
           
           
REDEEMABLE NON-CONTROLLING INTEREST   385    159 
           
EQUITY   181,809    178,293 
           
TOTAL LIABILITIES AND EQUITY    242,271    233,210 

 

* December 31, 2014 Balance Sheet was revised to reflect the acquisition of Insseco, in accordance with the pooling of interest method.

 

10  
 

 

Sapiens International Corporation N.V. AND ITS SUBSIDIARIES
Consolidated Statement of Cash Flow

U.S. dollars in thousands

 

 

  

For the year ended
December 31

 
   2015   2014 
   (unaudited)   (unaudited) 
Cash flows from operating activities:          
Net income   20,300    14,576 
           
Reconciliation of net income to net cash provided by operating activities:          
Depreciation  and amortization   9,625    8,717 
Amortization of premium and accrued interest on marketable securities   (453)   (225)
Stock-based compensation related to options issued to employees   1,349    1,067 
Decrease (increase) in trade receivables   1,893    (6,637)
Deferred tax assets   2,169    (1,020)
Decrease (increase) in other operating assets   (1,229)   127 
Increase (decrease)  in trade payables   1,511    (3,297)
Increase in other operating liabilities   4,134    8,469 
Increase (decrease)  in deferred revenues   1,300    (223)
Severance pay   (159)   7 
           
Net cash provided by operating activities   40,440    21,561 
           
Cash flows from investing activities:          
Purchase of property and equipment   (2,815)   (1,468)
Purchase of marketable securities   (7,678)   (34,906)
Proceeds from sales of marketable securities   1,499    1,543 
Payments for business acquisition, net of cash acquired   (2,934)   (2,064)
Capitalized software development costs   (6,032)   (6,094)
Decrease (increase) in restricted Cash   (893)   239 
           
Net cash used in investing activities   (18,853)   (42,750)
           
Cash flows from financing activities:          
Distribution of dividend   (7,186)   - 
Proceeds from employee stock options exercised   1,568    1,569 
Payment to shareholders in respect of acquisition   (8,482)   - 
Dividend to non-controlling interest   (77)   (106)
           
Net cash provided by (used in) financing activities   (14,177)   1,463 
           
Effect of exchange rate changes on cash and cash equivalents   (459)   (3,187)
           
Increase (decrease) in cash and cash equivalents   6,951    (22,913)
Cash and cash equivalents at the beginning of period   47,400    70,313 
           
Cash and cash equivalents at the end of period   54,351    47,400 

 

 

11